Het Antwerps Liedboek. 87 melodieën op teksten uit "Een Schoon Liedekens-Boeck" van 1544 K. Vellekoop H. Wagenaar-Nolthenius H. Nolthenius W. P. Gerritsen A. C. Hemmes-Hoogstadt

Publikováno v: Jahrbuch für Volksliedforschung, 1975 Jan 01. 20, 176-177.

Externí odkaz: https://www.jstor.org/stable/846669

Financing and Reimbursement Models for Personalised Medicine

Autor: Koleva-Kolarova, R, Buchanan, J, Vellekoop, H, Huygens, S, Versteegh, M, Mölken, MR-V, Szilberhorn, L, Zelei, T, Nagy, B, Wordsworth, S, Tsiachristas, A, Consortium, HEcoPerMed

Publikováno v: Applied Health Economics and Health Policy. 20(4):501-524

Background: The number of healthcare interventions described as ‘personalised medicine’ (PM) is increasing rapidly. As healthcare systems struggle to decide whether to fund PM innovations, it is unclear what models for financing and reimbursement

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbd7a142063744f8e7dc391e2c9cb38e
http://www.scopus.com/inward/record.url?scp=85130475829&partnerID=8YFLogxK

Cost-effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries.

Autor: Vellekoop H; Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands., Huygens S; Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands., Versteegh M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands., Szilberhorn L; Syreon Research Institute, Mexikoi str. 65/A, 1142 Budapest, Hungary., Zelei T; Syreon Research Institute, Mexikoi str. 65/A, 1142 Budapest, Hungary., Nagy B; Syreon Research Institute, Mexikoi str. 65/A, 1142 Budapest, Hungary., Koleva-Kolarova R; Health Economics Research Centre, University of Oxford, Oxford OX3 7LF, UK., Wordsworth S; Health Economics Research Centre, University of Oxford, Oxford OX3 7LF, UK., Rutten-van Mölken M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands.

Publikováno v: Personalized medicine [Per Med] 2023 Jul; Vol. 20 (4), pp. 321-338. Date of Electronic Publication: 2023 Sep 25.

Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies.

Autor: Nagy B; Syreon Research Institute, Budapest, Hungary.; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary., Zelei T; Syreon Research Institute, Budapest, Hungary., Vellekoop H; Institute for Medical Technology Assessment, Erasmus University Rotterdam, 3000 DR, Rotterdam, The Netherlands., Huygens S; Institute for Medical Technology Assessment, Erasmus University Rotterdam, 3000 DR, Rotterdam, The Netherlands., Versteegh M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, 3000 DR, Rotterdam, The Netherlands., Mölken MR; Institute for Medical Technology Assessment, Erasmus University Rotterdam, 3000 DR, Rotterdam, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Koleva-Kolarova R; Health Economics Research Centre, University of Oxford, Oxford, UK., Tsiachristas A; Health Economics Research Centre, University of Oxford, Oxford, UK., Wordsworth S; Health Economics Research Centre, University of Oxford, Oxford, UK., Szilberhorn L; Syreon Research Institute, Budapest, Hungary.

Publikováno v: Personalized medicine [Per Med] 2023 Jul; Vol. 20 (4), pp. 401-411. Date of Electronic Publication: 2023 Sep 11.

Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK.

Autor: Koleva-Kolarova R; Health Economics Research Centre, University of Oxford, Oxford, UK., Vellekoop H; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Huygens S; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Versteegh M; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Mölken MR; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Szilberhorn L; Syreon Research Institute, Budapest, Hungary.; Faculty of Social Sciences, Eötvös Loránd University, Budapest, Hungary., Zelei T; Syreon Research Institute, Budapest, Hungary., Nagy B; Syreon Research Institute, Budapest, Hungary., Wordsworth S; Health Economics Research Centre, University of Oxford, Oxford, UK.; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK., Tsiachristas A; Health Economics Research Centre, University of Oxford, Oxford, UK.; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UK.

Publikováno v: Personalized medicine [Per Med] 2023 Jul; Vol. 20 (4), pp. 339-355. Date of Electronic Publication: 2023 Sep 04.